Tetrandrine consequently reduces and increases the level of VEGF and BCL2-associated X protein (BAX), respectively [42], denoting the involvement of HIF-1α in the anti-angiogenic and apoptosis effects of tetrandrine in lung cancer. The gene discussed is BAX; the disease is lung carcinoma.